相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
Sarah Davis et al.
HEALTH TECHNOLOGY ASSESSMENT (2020)
Probabilistic Study of the Effect of Anti-Epileptic Drugs Under Uncertainty: Cost-Effectiveness Analysis
Isabel Barrachina-Martinez et al.
MATHEMATICS (2020)
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
M. Hiligsmann et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China
Na Li et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2019)
Cost-Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate-Alone Strategies in High-Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
Takahiro Mori et al.
JBMR PLUS (2019)
Recommendations by the Spanish Society of Rheumatology on Osteoporosis
Antonio Naranjo Hernandez et al.
REUMATOLOGIA CLINICA (2019)
Cost-effectiveness analysis of drugs for osteoporosis treatment in elderly Japanese women at high risk of fragility fractures: comparison of denosumab and weekly alendronate
Tomohiro Yoshizawa et al.
ARCHIVES OF OSTEOPOROSIS (2018)
Randomizing the parameters of a Markov chain to model the stroke disease: A technical generalization of established computational methodologies towards improving real applications
J. -C. Cortes et al.
JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS (2017)
Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan
T. Mori et al.
OSTEOPOROSIS INTERNATIONAL (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia
Jonathan Karnon et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2016)
Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis
Lanling Zhang et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS)
J. Abimanyi-Ochom et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Cost-effective osteoporosis treatment thresholds in Greece
P. Makras et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
Josep Darba et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2015)
Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective
A. Parthan et al.
BONE (2014)
Osteoporosis in the European Union: a compendium of country-specific reports
A. Svedbom et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US
Anju Parthan et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
Daniel R. Murphy et al.
BMC MUSCULOSKELETAL DISORDERS (2012)
Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
N. Freemantle et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk
S. Boonen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)
A. Fahrleitner-Pammer et al.
OSTEOPOROSIS INTERNATIONAL (2011)
A proposed guideline for economic evaluation of health technologies
Julio Lopez Bastida et al.
GACETA SANITARIA (2010)
Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral
J. González Macías et al.
REVISTA CLINICA ESPANOLA (2009)
What does the value of modern medicine say about the $50,000 per Quality-Adjusted Life-Year decision rule?
R. Scott Braithwaite et al.
MEDICAL CARE (2008)
Interpretation of SF-36 and SF-12 questionnaires in Spain:: physical and mental components
Gernma Vilagut et al.
MEDICINA CLINICA (2008)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries -: an economic evaluation based on the fracture intervention trial
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2007)
The cost-effectiveness of risedronate in the treatment of osteoporosis:: an international perspective
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Requirements for DXA for the management of osteoporosis in Europe
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
N Devlin et al.
HEALTH ECONOMICS (2004)
A meta-analysis of previous fracture and subsequent fracture risk
JA Kanis et al.
BONE (2004)
National Institute for Clinical Excellence and its value judgments
MD Rawlins et al.
BRITISH MEDICAL JOURNAL (2004)
What is osteoporosis?
C Christodoulou et al.
POSTGRADUATE MEDICAL JOURNAL (2003)
Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis
CM Klotzbuecher et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
